ATOSSA THERAPEUTICS, INC.

ATOS · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 14 employees
308
SEC Filings
$2.12
Close 2026-11-04
14
Employees

Business Summary

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for breast cancer and other diseases. Its lead product candidate is (Z)-endoxifen, an active metabolite of Tamoxifen, being studied in women with breast cancer and for Duchenne muscular dystrophy (DMD). The company is pursuing FDA approval and has applied for Rare Pediatric Disease Priority Review Voucher and orphan-drug exclusivity designations for DMD.

Latest Stock Quote

ATOS 2026-11-04 $2.12 O:$2.33 H:$2.3499 L:$2.1 Vol:0.1M VWAP:$2.1935
origin leaf: null

Next Earnings

expected 2026-12-18

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-252025-12-310001193125-26-124396EDGAR59K words
2025-03-252024-12-310000950170-25-044099EDGAR54K words
2024-04-012023-12-310000950170-24-039306EDGAR60K words
2023-03-222022-12-310001437749-23-007531EDGAR54K words
2022-02-282021-12-310001437749-22-004614EDGAR56K words
2021-03-312020-12-310001437749-21-007756EDGAR54K words
2020-03-262019-12-310001437749-20-006155EDGAR48K words
2019-03-282018-12-310001437749-19-005927EDGAR52K words
2018-03-082017-12-310001615774-18-001693EDGAR53K words
2017-03-162016-12-310001615774-17-001088EDGAR61K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-102026-09-300001193125-26-454468EDGAR38K words
2026-08-072026-06-300001193125-26-339257EDGAR36K words
2025-11-122025-09-300001193125-25-276160EDGAR35K words
2025-08-122025-06-300000950170-25-106947EDGAR34K words
2025-05-132025-03-310000950170-25-069827EDGAR33K words
2024-11-122024-09-300000950170-24-124668EDGAR34K words
2024-08-122024-06-300000950170-24-095102EDGAR32K words
2024-05-132024-03-310000950170-24-058244EDGAR31K words
2023-11-132023-09-300001437749-23-031424EDGAR38K words
2023-08-142023-06-300001437749-23-023426EDGAR37K words
2023-05-152023-03-310001437749-23-014366EDGAR34K words
2022-11-072022-09-300001437749-22-026178EDGAR32K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-100001193125-26-454486EDGAR4K words
2026-10-090001193125-26-418560EDGAR1K words
2026-09-290001193125-26-406036EDGAR1K words
2026-09-180001193125-26-395694EDGAR4K words
2026-08-070001193125-26-339292EDGAR4K words
2026-03-250001193125-26-124393EDGAR3K words
2026-02-200001193125-26-061412EDGAR22K words
2026-02-170001193125-26-054797EDGAR1K words
2026-02-110001193125-26-045628EDGAR2K words
2026-01-260001193125-26-021727EDGAR1K words

308 total filings indexed. 276 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

breast-cancer-therapeutics rare-pediatric-diseases-(duchenne-muscular-dystrophy)

Company Identity

CIK0001488039
TickerATOS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.atossatherapeutics.com
Listed2012-11-08

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 28348331d3c665d118ad01dd311480fbc340f2ec4b88c53ec91de9eb19da159c
parent: 61f9cf4d2b23e7072370a3277b6ecc93c7acb63731e3a0e08098a0f12a5c5d01
content hash: 53d6eff09884c3eaed97064494ba3fc869285c60ad94432b3de57c9752d2ad6a
signed: 2026-11-16T19:00:46.899Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ATOS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ATOS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ATOS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.